Induction agent that may cause adrenal cortex suppression is
**Core Concept**
The question tests knowledge of **anesthesia induction agents** and their side effects, specifically focusing on **adrenal cortex suppression**. This is a critical aspect of pharmacology in anesthesia, as it can have significant implications for patient care. **Etomidate** is an induction agent known for its potential to cause adrenal insufficiency.
**Why the Correct Answer is Right**
**Etomidate** inhibits the enzyme **11-beta-hydroxylase**, which is crucial for the production of **cortisol** in the adrenal cortex. This inhibition can lead to **adrenal cortex suppression**, resulting in decreased cortisol levels. The clinical significance of this side effect makes it a critical consideration in the choice of induction agents, particularly in patients who may already have compromised adrenal function.
**Why Each Wrong Option is Incorrect**
**Option A:** Other induction agents like **propofol** do not have a significant impact on adrenal cortex function.
**Option B:** **Ketamine** has various side effects but adrenal cortex suppression is not a primary concern.
**Option D:** **Midazolam**, a benzodiazepine, is used for sedation and does not cause significant adrenal suppression.
**Clinical Pearl / High-Yield Fact**
It's crucial to remember that **etomidate**'s effect on the adrenal cortex can be particularly problematic in critically ill patients or those undergoing long-term treatment, as it may exacerbate **adrenal insufficiency**. Monitoring and potentially supplementing with **hydrocortisone** may be necessary in these cases.
**Correct Answer:** D. Etomidate.